Perigord secures funding from the BDO Development Capital Fund to expand its global network in the life sciences sector.
Target Company Overview
Perigord, based in Dublin and employing over 100 people, is dedicated to advancing new developments within the life sciences sector. The company is focused on enhancing its operations by establishing new hubs in America, Asia, and Latin America. This global expansion aims to create a comprehensive platform to serve the life sciences sector and provide effective global solutions.
Industry Overview in Ireland
The life sciences industry in Ireland is a dynamic and rapidly growing sector, bolstered by a strong regulatory framework and a burgeoning ecosystem of innovation. The country has become a hub for biopharmaceutical companies, attracting significant investment due to its skilled workforce and favorable business environment. Ireland's strategic location within Europe further enhances its appeal, facilitating access to a large market.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
In recent years, the industry has seen an uptick in the number of life science companies establishing operations in Ireland, with many global leaders setting up manufacturing
Similar Deals
Claret Capital Partners → Deciphex
2025
Gilde Healthcare, Viking Global Investors → Mainstay Medical Holdings plc
2024
BGF → Avoca Clinic
2023
Unmind → Frankie Health
2023
Beechbrook Capital → Bio-Medical Research Limited
2019
BDO Development Capital Fund → Lifes2good Group
2015
BDO Development Capital Fund
invested in
Perigord
in
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $80M